HEAL IST FDA trial NCT05280093

De Asmundis, C. (Advisor)

Cardio-vascular diseases
Clinical sciences
Heartrhythmmanagement

Activity: Consultancy › Joint or sponsored appointments or secondments with industry and commerce

Description

Inappropriate Sinus Tachycardia (IST) is a prevalent and debilitating condition in otherwise healthy younger patients, resulting in significant loss of quality of life, lacking effective treatment options or systematic clinical evidence to support a therapy. The primary objective of this clinical trial is to evaluate the safety and effectiveness of a hybrid sinus node sparing ablation procedure for the treatment of symptomatic drug refractory or drug intolerant IST.

Period	31 May 2022 → …
Work for	AtriCure, United States
Degree of Recognition	International